Trials / Completed
CompletedNCT03097393
Serum Procalcitonin Level May Predict Acute Kidney Injury in ICU Patients With Sepsis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 67 (actual)
- Sponsor
- Benha University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to examine if procalcitonin (PCT) can be used for early prediction of AKI septic patients in ICU.
Detailed description
67 patients with sepsis were enrolled in this study. On admission, PCT was measured together with serum creatinine, urea, and other inflammatory markers. Quick Sepsis-related Organ Failure Assessment was calculated at the emergency department. Patients were classified into those with Acute kidney injury (AKI) and non-AKI groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | measure Serum procalcitonin level | measuring procalcitonin level |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2017-02-28
- Completion
- 2017-03-01
- First posted
- 2017-03-31
- Last updated
- 2017-03-31
Source: ClinicalTrials.gov record NCT03097393. Inclusion in this directory is not an endorsement.